【摘要】 目的　了解辅助生殖技术 (ART)周期中宫腔积液对临床结果的影响。方法　对 2 0 0 1年 1月至 2 0 0 2年 1 2月 2年内在湘雅医院生殖医学中心接受ART治疗 (IVF/ICSI ET)的 4 6 2对不育夫妇 5 2 7个治疗周期进行分析 ,判断宫腔积液与不孕原因、胚胎植入率、临床妊娠率之间关系。结果　宫腔积液在ART周期中发生率为4 74 %。在输卵管因素中B超下可见输卵管积液患者发生宫腔积液 (1 7 0 2 % )明显高于B超下未见输卵管积液患者 (3 1 8% ) ,P <0 0 1 ,经积极处理 ,宫腔积液者与无宫腔积液者胚胎植入率、临床妊娠率差异无显著性意义(P >0 0 5 )。结论　B超下可见输卵管积液患者ART周期中宫腔积液发生率增高 ,且在ART周期宫腔积液经积极处理不影响临床妊娠率更多还原

【Abstract】 Objective To investigate the role of endometrial cavity fluid (ECF) in assisted reproductive technology (ART) cycles and its influence on clinical pregnancy.Methods A retrospective analysis was performed on 527 ART cycles from January 2001 to December 2002.The relationship between ECF and infertility factors,embryo implantation rate and pregnancy rate was estimated.Results The incidence of ECF in ART cycles was 4 74%.In the tubal factor group,ECF was found in 17 02% of women with ultrasound visible hydrosalpinges compared with 3 18% with non ultrasound visible hydrosalpinges (P<0 01).The embryo implantation rate and pregnancy rate were similar compared with that of non ECF after proper treatments (P>0 05).Conclusion The incidence of ECF is higher in women with ultrasound visible hydrosalpinges than those with other infertility factors.After proper treatment,ECF has no influence on clinical pregnancy.更多还原